Reduced Dynamic Complexity of BOLD Signals Differentiates Mild Cognitive Impairment From Normal Aging.

BOLD complexity imaging biomarker mild cognitive impairment multi-scale entropy resting-state fMRI

Journal

Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824

Informations de publication

Date de publication:
2020
Historique:
received: 07 10 2019
accepted: 17 03 2020
entrez: 24 4 2020
pubmed: 24 4 2020
medline: 24 4 2020
Statut: epublish

Résumé

Mild cognitive impairment (MCI) is characterized as a transitional phase between cognitive decline associated with normal aging and Alzheimer's disease (AD). Resting-state functional magnetic resonance imaging (fMRI) measuring blood oxygenation level-dependent (BOLD) signals provides complementary information considered essential for understanding disease progression. Previous studies suggested that multi-scale entropy (MSE) analysis quantifying the complexity of BOLD signals is a novel and promising method for investigating neurodegeneration associated with cognitive decline in different stages of MCI. Therefore, the current study used MSE to explore the changes in the complexity of resting-state brain BOLD signals in patients with early MCI (EMCI) and late MCI (LMCI). We recruited 345 participants' data from the Alzheimer's Disease Neuroimaging Initiative database, including 176 normal control (NC) subjects, 87 patients with EMCI and 82 patients with LMCI. We observed a significant reduction of brain signal complexity toward regularity in the left fusiform gyrus region in the EMCI group and in the rostral anterior cingulate cortex in the LMCI group. Our results extend prior work by revealing that significant reductions of brain BOLD signal complexity can be detected in different stages of MCI independent of age, sex and regional atrophy. Notably, the reduction of BOLD signal complexity in the rostral anterior cingulate cortex was significantly associated with greater risk of progression to AD. The present study thus identified MSE as a potential imaging biomarker for the early diagnosis of pre-clinical Alzheimer's disease and provides further insights into the neuropathology of cognitive decline in prodromal AD.

Identifiants

pubmed: 32322197
doi: 10.3389/fnagi.2020.00090
pmc: PMC7156890
doi:

Types de publication

Journal Article

Langues

eng

Pagination

90

Subventions

Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States

Informations de copyright

Copyright © 2020 Zheng, Onoda, Nagai and Yamaguchi.

Références

J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Hum Brain Mapp. 2015 Jun;36(6):2174-86
pubmed: 25664834
Trends Cogn Sci. 2011 Feb;15(2):85-93
pubmed: 21167765
Neuroimage. 2017 Nov 15;162:322-343
pubmed: 28882629
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13642-7
pubmed: 23898179
Lancet Neurol. 2015 Oct;14(10):1037-53
pubmed: 26318837
JAMA Neurol. 2013 Aug;70(8):1030-8
pubmed: 23797806
J Cogn Neurosci. 2016 Jul;28(7):971-84
pubmed: 26942319
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):526-36
pubmed: 26555082
Neurobiol Aging. 2013 Feb;34(2):428-38
pubmed: 22683008
J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):121-5
pubmed: 21677237
Cortex. 2017 Jan;86:83-92
pubmed: 27930899
J Neurosci Methods. 1994 Oct;54(2):171-87
pubmed: 7869750
Neuroreport. 2014 Dec 3;25(17):1393-8
pubmed: 25325351
Front Neurosci. 2018 Oct 23;12:770
pubmed: 30405347
Lancet. 2006 Apr 15;367(9518):1262-70
pubmed: 16631882
J Neurosci. 2018 Feb 14;38(7):1744-1755
pubmed: 29330327
Neuron. 2006 Sep 21;51(6):871-82
pubmed: 16982430
J Comp Neurol. 2008 Jun 20;508(6):906-26
pubmed: 18404667
Lancet. 2001 Jul 21;358(9277):201-5
pubmed: 11476837
Phys Rev Lett. 2002 Apr 29;88(17):174102
pubmed: 12005759
Brain Imaging Behav. 2014 Jun;8(2):284-91
pubmed: 24242271
Lancet Neurol. 2011 Sep;10(9):829-43
pubmed: 21778116
Alzheimers Dement. 2017 Apr;13(4):e1-e85
pubmed: 28342697
Am J Physiol Heart Circ Physiol. 2000 Jun;278(6):H2039-49
pubmed: 10843903
Soc Cogn Affect Neurosci. 2017 Mar 1;12(3):476-486
pubmed: 27998997
Alzheimers Dement (Amst). 2018 Apr 26;10:382-393
pubmed: 29984299
Front Neurosci. 2018 Jun 13;12:398
pubmed: 29950971
Biomed Opt Express. 2018 Mar 26;9(4):1916-1929
pubmed: 29675329
Brain Connect. 2012;2(3):125-41
pubmed: 22642651
Neuroimage. 2018 Jun;173:604-609
pubmed: 29471101
Hum Brain Mapp. 2018 Jul;39(7):2997-3004
pubmed: 29676512
Cereb Cortex. 2014 Jul;24(7):1806-17
pubmed: 23395850
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2297-301
pubmed: 11607165
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9868-72
pubmed: 2124706
Front Aging Neurosci. 2017 Nov 20;9:378
pubmed: 29209199
J Alzheimers Dis. 2014;42(1):275-89
pubmed: 24844687
Neuroimage. 2014 Jul 1;94:275-286
pubmed: 24657351
J Alzheimers Dis. 2016 Oct 4;54(3):983-993
pubmed: 27567874

Auteurs

Haixia Zheng (H)

Laureate Institute for Brain Research, Tulsa, OK, United States.

Keiichi Onoda (K)

Department of Neurology, Faculty of Medicine, Shimane University, Izumo, Japan.

Atsushi Nagai (A)

Department of Neurology, Faculty of Medicine, Shimane University, Izumo, Japan.

Shuhei Yamaguchi (S)

Department of Neurology, Faculty of Medicine, Shimane University, Izumo, Japan.

Classifications MeSH